1. Home
  2. NEOG vs IMTX Comparison

NEOG vs IMTX Comparison

Compare NEOG & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neogen Corporation

NEOG

Neogen Corporation

HOLD

Current Price

$6.86

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Immatics N.V.

IMTX

Immatics N.V.

HOLD

Current Price

$10.00

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEOG
IMTX
Founded
1981
N/A
Country
United States
Germany
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
1989
N/A

Fundamental Metrics

Financial Performance
Metric
NEOG
IMTX
Price
$6.86
$10.00
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$8.83
$19.25
AVG Volume (30 Days)
4.2M
590.7K
Earning Date
01-09-2026
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$886,886,000.00
$99,445,031.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.80
$24.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.87
$3.30
52 Week High
$13.41
$12.41

Technical Indicators

Market Signals
Indicator
NEOG
IMTX
Relative Strength Index (RSI) 65.40 48.62
Support Level $5.82 $9.86
Resistance Level $7.09 $12.41
Average True Range (ATR) 0.27 0.71
MACD 0.11 -0.10
Stochastic Oscillator 81.64 9.40

Price Performance

Historical Comparison
NEOG
IMTX

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

About IMTX Immatics N.V.

Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.

Share on Social Networks: